Cidara Therapeutics (CDTX) Announces Proposed $30M Rights Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow rise as AI boost counters US-Iran tensions
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
Cidara Therapeutics Announces Proposed Rights Offering
January 10, 2020 8:00 AM ESTRights Offering will be available to all stockholders and 2018 warrant holders of record on January 21, 2020
$30.0 million to be raised, fully backstopped
SAN DIEGO, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (Cidara) today announced its intent to raise $30.0 million through a fully backstopped rights offering. Under the terms of the rights offering, investors as of January 21, 2020 in Cidaras common stock and preferred stock, as well as the holders of Cidaras warrants issued on May 21, 2018, will receive a subscription right entitling them to... More
